Correspondence 0001062993-25-002152 from BRIGHT MINDS BIOSCIENCES INC. (DRUG)

BRIGHT MINDS BIOSCIENCES INC.
Date: Feb. 12, 2025 · CIK: 0001827401 · Accession: 0001062993-25-002152

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-284694

Date

February 12, 2025

Author

Ian McDonald

Form

CORRESP

Company

BRIGHT MINDS BIOSCIENCES INC.

Letter

VIA EDGAR Correspondence United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes, Division of Corporation Finance, Office of Life Sciences

Dear Sirs/Mesdames:

Re:

Bright Minds Biosciences Inc. (the "Company")

Registration Statement on Form F-3 filed February 5, 2025 File No. 333-284694

Acceleration Request for Registration Statement

Bright Minds Biosciences Inc., as the registrant of the above-captioned registration statement, hereby respectfully requests of the United States Securities and Exchange Commission that the registration statement be permitted to become effective at 4:15 p.m., Washington, D.C. time, on Friday, February 14, 2025, or as soon thereafter as is practicable. Please advise our counsel, Michael Shannon of McMillan LLP, at telephone direct: (604) 893-7638 or email: Michael.shannon@mcmillan.ca, of any questions you may have respecting this request.

Yours very truly,

BRIGHT MINDS BIOSCIENCES INC.

Per: /s/ Ian McDonald

Name: Ian McDonald

Title: Chief Executive Officer

(Principal Executive Officer)

Show Raw Text

CORRESP
1
filename1.htm

    Bright Minds Biosciences Inc.: CORRESP - Filed by newsfilecorp.com

    VIA EDGAR Correspondence

    February 12, 2025

    United States Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.
Washington, D.C.  20549

    Attention: Tyler Howes, Division of Corporation Finance, Office of Life Sciences

    Dear Sirs/Mesdames:

    Re:

    Bright Minds Biosciences Inc. (the "Company")

    Registration Statement on Form F-3 filed February 5, 2025
File No. 333-284694

    Acceleration Request for Registration Statement

    Bright Minds Biosciences Inc., as the registrant of the above-captioned registration statement, hereby respectfully requests of the United States Securities and Exchange Commission that the registration statement be permitted to become effective at 4:15 p.m., Washington, D.C. time, on Friday, February 14, 2025, or as soon thereafter as is practicable.  Please advise our counsel, Michael Shannon of McMillan LLP, at telephone direct: (604) 893-7638 or email: Michael.shannon@mcmillan.ca, of any questions you may have respecting this request.

    Yours very truly,

    BRIGHT MINDS BIOSCIENCES INC.

    Per: /s/ Ian McDonald

    Name: Ian McDonald

    Title: Chief Executive Officer

    (Principal Executive Officer)

SecProbe.io